Although FXR-deficient mice are resistant to HFD-induced obesity, FXR agonists protect the liver from inflammation and fibrosis in the non-alcoholic steatohepatitis mouse model [64]. The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.